To initiate joint research aiming to create innovative cancer drugs in Targeted Alpha Therapy［PDF:457.7 KB］

Mitsubishi Tanabe Pharma Corporation published this content on July 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 10, 2025 at 04:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io